UCB showcases decade of growth and Patient Value Strategy driving differentiated innovationBreakthrough innovation, differentiated solutions and cutting-edge pipeline to unlock growth for a decade+ ...

The upcoming report from United Community Banks (UCB) is expected to reveal quarterly earnings of $0.56 per share, indicating an increase of 5.7% compared to the year-ago period. Analysts forecast ...

UCB announced that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX is now available.

Barclays analyst Charles Pitman CFA maintained a Buy rating on UCB SA (0NZT – Research Report) yesterday and set a price target of €240.00. The ...

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

United Community Banks (UCB) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial ...

CHATHAM The Board of Directors of United Community Bank (UCB) is pleased to announce that Allen Schmale has been named ...

GET MORE AI-GENERATED SIGNALS: January 10, 2025, 13:48 pm ET, BY Joseph H.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Under the agreement, UCB gains a non-exclusive license to leverage XtalFold for the discovery and engineering of biologics.